A critical analysis of low molecular weight heparin use during pregnancy in a tertiary referral centre

References

• Alfirevic Z, Roberts D, Martlew V. 2002. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. European Journal of Obstetrics, Gynecology, and Reproductive Biology 101:6–14.
   PubMed Web of Science ®Google Scholar
• Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO; American College of Chest Physicians. 2012. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:691–736.
   Google Scholar
• Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J; LIVE-ENOX Investigators. 2005. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. Journal of Thrombosis and Haemostasis 3:227–229.
   PubMed Web of Science ®Google Scholar
• de Jong PG, Goddijn M, Middeldorp S. 2011. Testing for inherited thrombophilia in recurrent miscarriage. Seminars in Reproductive Medicine 29:540–547.
   PubMed Web of Science ®Google Scholar
• Ellison J, Walker ID, Greer IA. 2000. Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy. British Journal of Obstetrics and Gynaecology 107:1116–1121.
   Google Scholar
• Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T et al. 2000. Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Human Reproduction 15:458–462.
   PubMed Web of Science ®Google Scholar
• Forestier F, Daffos F, Rainaut M, Toulemonde F. 1987. Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy. Thrombosis and Haemostasis 57:234.
   PubMed Web of Science ®Google Scholar
• Hayes-Ryan D, Byrne BM. 2012. Prevention of thrombosis in pregnancy: How practical are consensus derived clinical practice guidelines? Journal of Obstetrics and Gynaecology 32:740–742.
   Web of Science ®Google Scholar
• Hodes-Wertz B, Grifo J, Ghadir S, Kaplan B, Laskin CA, Glassner M et al. 2012. Idiopathic recurrent miscarriage is caused mostly by aneuploid embryos. Fertility and Sterility 98:675–680.
   PubMed Web of Science ®Google Scholar
• Jaslow CR, Carney JL, Kutteh WH. 2010. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertility and Sterility 93:1234–1243.
   PubMed Web of Science ®Google Scholar
• Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. 2009. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database of Systematic Reviews 21:CD004734.
   Google Scholar
• Kominiarek MA, Angelopoulos SM, Shapiro NL, Studee L, Nutescu EA, Hibbard JU. 2007. Low-molecular-weight heparin in pregnancy: peripartum bleeding complications. Journal of Perinatology 27:329–334.
   PubMed Web of Science ®Google Scholar
• Kosar A, Kasapoglu B, Kalyoncu S, Turan H, Balcik OS, Gümüs EI. 2011. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study. Blood Coagulation and Fibrinolysis 22:14–18.
   PubMed Web of Science ®Google Scholar
• Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA et al. 2009. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. Journal of Rheumatology 36:279–287.
   PubMed Web of Science ®Google Scholar
• Lindqvist PG, Dahlbäck B. 2003. Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women. Acta Obstetricia et Gynecologica Scandinavica 82:467–470.
   PubMed Web of Science ®Google Scholar
• Lykke JA, Bare LA, Olsen J, Lagier R, Arellano AR, Tong C et al. 2012. Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort. Journal of Thrombosis and Haemostasis 10:1320–1325.
   PubMed Web of Science ®Google Scholar
• Mak A, Cheung MW, Cheak AA, Ho RC. 2010. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta regression. Rheumatology 49:281–288.
   PubMed Web of Science ®Google Scholar
• Mantha S, Bauer KA, Zwicker JI. 2010. Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review. Journal of Thrombosis and Haemostasis 8:263–268.
   PubMedGoogle Scholar
• Ozarda Y, Sucu DK, Hizli B, Aslan D. 2009. Rate of T alleles and TT genotype at MTHFR 677C-> T locus or C alleles and CC genotype at MTHFR 1298A-> C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals. Cell Biochemistry and Function 27:568–577.
   PubMedGoogle Scholar
• Patel JP, Hunt BJ. 2008. Where do we go now with low molecular weight heparin use in obstetric care? Journal of Thrombosis and Haemostasis 6:1461–1467.
   PubMedGoogle Scholar
• Said JM, Higgins JR, Moses EK, Walker SP, Monagle PT, Brennecke SP. 2012. Inherited thrombophilias and adverse pregnancy outcomes: a case-control study in an Australian population. Acta Obstetricia et Gynecologica Scandinavica 91:250–255.
   PubMed Web of Science ®Google Scholar
• Salomon O, Seligsohn U, Steinberg DM, Zalel Y, Lerner A, Rosenberg N et al. 2004. The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction. American Journal of Obstetrics and Gynecology 191:2002–2009.
   PubMedGoogle Scholar
• Santoro R, Iannaccaro P, Prejanò S, Muleo G. 2009. Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy. Blood Coagulation and Fibrinolysis 20:240–243.
   PubMedGoogle Scholar
• Siragusa S, Cosmi B, Piovella F, Hirsh J, Ginsberg JS. 1996. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. American Journal of Medicine 100:269–277.
   PubMed Web of Science ®Google Scholar
• Sucak A, Acar K, Celen S, Danisman N, Sucak GT. 2010. Outcome of pregnancies in women with thrombophilic disorders. Journal of Obstetrics and Gynaecology 30:847–851.
   Web of Science ®Google Scholar
• Üçer AR. 2012. Big-Pharma Dünyayı Denetliyor [The Big-Pharma Inspects the World] In: Arslanoğlu I (ed.) Tıp Bu Değil [This is not medicine]. Istanbul: İthaki Publishing.
   Google Scholar
• Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M et al. 1995. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. New England Journal of Medicine 332:1330–1335.
   PubMed Web of Science ®Google Scholar